Our study demonstrates that the overactivation of the AKT/β-catenin pathway contributes to maintaining MDR in tumor cells, mediated by the ATP binding cassette family's transport functions and anti-apoptotic mechanisms. This evidence concerns the gene AKT1 and neoplasm.